Chinese defence-manufacturing companies saw a significant stock rally on Wednesday, driven by heightened India-Pakistan border tensions following India’s missile strikes. The surge reflects growing demand for Chinese military exports, particularly to Pakistan, amid regional conflict.
On May 7, 2025, shares of Chinese defence firms, including Chengdu Aircraft Corporation, surged by 11.85%, as reported by Bloomberg. This surge was fueled by escalating India-Pakistan hostilities.
Shares of Chinese defense-manufacturing companies rallied on Wednesday, as the escalation in border tensions between India and Pakistan boosted the outlook for mainland exporters. https://t.co/q540dSr5vq
— Bloomberg (@business) May 7, 2025Pakistan’s military, equipped with Chinese J-10C and JF-17 jets, downed five Indian aircraft, including Rafales, during India’s airstrikes on civilian targets, prompting speculation about the effectiveness of Chinese platforms, per Reuters. The rally, noted on X, highlights China’s role as Pakistan’s primary arms supplier, with exports like the SH-15 howitzer bolstering its defence market outlook.
The tensions, sparked by the April 22 Pahalgam attack in Indian-administered Kashmir, which killed 26, have led to India’s retaliatory strikes and Pakistan’s robust response, per Al Jazeera. According to The Economic Times, this conflict has boosted investor confidence in Chinese defence exporters, with analysts citing potential for increased contracts.
Read: Pakistan Downs 5 Indian Jets, Drone in Response to Airstrikes
China’s strategic partnership with Pakistan, particularly through initiatives like the China-Pakistan Economic Corridor, enhances its influence in the defence export market.
The United States and the United Nations have called for de-escalation. At the same time, China’s Foreign Minister, Wang Yi, has backed Pakistan’s request for a neutral investigation into the situation in Pahalgam, according to DW. However, this rally has raised concerns about exploiting the conflict for profit, with some posts on X questioning the ethics of defence stock gains amid civilian casualties.
